Ocular actions of platelet-activating factor: clinical implications

Author： Nitoda Eirini   Moschos Marilita M   Mavragani Clio P   Koutsilieris Michael  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.10, 2012-10, pp. : 1027-1039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current status of platelet-activating factor antagonists

By Curtin M.L.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 703-711

Informa Healthcare

Access to resources Recommend Favorite

Endogenous corticosteroids mediate the neutrophilia caused by platelet-activating factor in the mouse

By Harris J.G.   Flower R.J.   Perretti M.  

European Journal of Pharmacology, Vol. 283, Iss. 1, 1995-09 ,pp. : 9-18

Elsevier

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea

By Costuleanu M.   Brailoiu E.   Filipeanu C.M.   Baltatu O.   Slatineanu S.   Saila L.   Nechifor M.   Branisteanu D.D.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 89-92

Elsevier

Access to resources Recommend Favorite

Inhibitory effect of arachidonic acid on platelet-activating factor production in rat neutrophils

By Naraba H.   Ueno A.   Matsumoto H.   Oh-ishi S.  

European Journal of Pharmacology, Vol. 302, Iss. 1, 1996-04 ,pp. : 117-121

Elsevier

Access to resources Recommend Favorite